Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Slater

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cancer Research|October 1, 1972
The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selectionH Wallerstein, L M Slater, B Eng, et al.
Cancer|August 15, 1985
Mondor's disease associated with metastatic axillary nodesD R Miller, T C Cesario, L M Slater
British Journal of Cancer|December 1, 1991
Development of cyclosporin A mediated immunity in L1210 leukaemiaL M Slater, M Wetzel, J Cho, et al.
Journal of the National Medical Association|April 1, 1982
Adult nephrotic syndrome and acquired coagulopathies: Hageman factor deficiencyH E Branson, N D Vaziri, L M Slater
Cancer Chemotherapy and Pharmacology|January 1, 1987
Third trimester chemotherapy and neonatal hematopoiesisJ M Meador, S A Armentrout, L M Slater
Blood|November 1, 1971
Reversal of resistance to methotrexate in L1210 murine leukemia by uracilH Wallerstein, L M Slater, B Eng, et al.
The Journal of Clinical Investigation|April 1, 1986
Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitroL M Slater, P Sweet, M Stupecky, et al.
Cancer|November 1, 1979
Remission of pure red cell aplasia associated with nonthymic malignancyL M Slater, M J Schlutz, S A Armentrout
Cancer Chemotherapy and Pharmacology|January 1, 1984
Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinomaS L Murray, E M Du Vall, L M Slater
Clinical Immunology and Immunopathology|June 1, 1995
Cyclosporin A/VP-16 produced immunity to L1210 leukemia: the participation of cytotoxic CD8 T-lymphocytesL M Slater, P Sweet, M Stupecky, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cancer Research|October 1, 1972
The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selectionH Wallerstein, L M Slater, B Eng, et al.
Cancer|August 15, 1985
Mondor's disease associated with metastatic axillary nodesD R Miller, T C Cesario, L M Slater
British Journal of Cancer|December 1, 1991
Development of cyclosporin A mediated immunity in L1210 leukaemiaL M Slater, M Wetzel, J Cho, et al.
Journal of the National Medical Association|April 1, 1982
Adult nephrotic syndrome and acquired coagulopathies: Hageman factor deficiencyH E Branson, N D Vaziri, L M Slater
Cancer Chemotherapy and Pharmacology|January 1, 1987
Third trimester chemotherapy and neonatal hematopoiesisJ M Meador, S A Armentrout, L M Slater
Blood|November 1, 1971
Reversal of resistance to methotrexate in L1210 murine leukemia by uracilH Wallerstein, L M Slater, B Eng, et al.
The Journal of Clinical Investigation|April 1, 1986
Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitroL M Slater, P Sweet, M Stupecky, et al.
Cancer|November 1, 1979
Remission of pure red cell aplasia associated with nonthymic malignancyL M Slater, M J Schlutz, S A Armentrout
Cancer Chemotherapy and Pharmacology|January 1, 1984
Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinomaS L Murray, E M Du Vall, L M Slater
Clinical Immunology and Immunopathology|June 1, 1995
Cyclosporin A/VP-16 produced immunity to L1210 leukemia: the participation of cytotoxic CD8 T-lymphocytesL M Slater, P Sweet, M Stupecky, et al.
Pageof 5